# Rhythm Pharmaceuticals Shares Rise 5.4%

> Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target.
- Title: Rhythm Pharmaceuticals Shares Rise 5.4% · TokenPost | Shortify
- Summary: Rhythm Pharmaceuticals shares climb 5.4% as Eli Lilly evaluates obesity market acquisition target. Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m.
- Keywords: rhythm pharmaceuticals, obesity market, acquisition target, shares, crypto, TokenPost
- URL: https://shortify.news/TokenPost/rhythm-pharmaceuticals-shares-rise-54
- Source: TokenPost — https://tokenpost.com/news/business/59688
- Published: 2026-11-17T17:36:02+00:00
- Read time: 1 min
- Topics: rhythm pharmaceuticals, obesity market, acquisition target, shares, crypto, finance
## Rhythm Pharmaceuticals Shares
Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17.
## Eli Lilly Evaluation
Eli Lilly reportedly evaluating Rhythm Pharmaceuticals as potential obesity market acquisition target.
## Viking Therapeutics Speculation
Viking Therapeutics also part of obesity market acquisition speculation.
## Key takeaway

Rhythm Pharmaceuticals shares rose 5.4% at 12:22 p.m. ET on November 17 after Eli Lilly reportedly considered acquiring the company for obesity market expansion.

---

Summary: Shortify — https://shortify.news/TokenPost/rhythm-pharmaceuticals-shares-rise-54
Reporting: TokenPost — https://tokenpost.com/news/business/59688

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.